Philip B.
- Country
- Germany
- Department
- Klinik für Paediatrie m. S. Gastroenterologie, Nephrologie und Stoffwechselmedizin
Research Overview
- A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
- Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial
- An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia (BOLD-EXT)
Data & Insights
Has run more than one trial at 44 of 87 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating pediatric patients with inflammatory bowel diseases, focusing particularly on ulcerative colitis and Crohn's disease. Their expertise extends to evaluating advanced therapeutic approaches for managing moderate to severe cases.
- Pediatric Ulcerative Colitis Treatment
- Crohn's Disease Therapy
- Novel Biologic Treatments
Their work includes investigating innovative treatment modalities including fecal microbiota transplantation and biological therapies.
Hepatobiliary Disorders
The investigator demonstrates significant expertise in treating pediatric hepatobiliary disorders, with particular focus on biliary atresia and Alagille syndrome. Their research encompasses long-term management strategies for these conditions.
- Biliary Atresia Management
- Post-Kasai Procedure Care
- Alagille Syndrome Treatment
The investigator's work includes evaluating treatments for improving native liver survival and managing pruritus in affected patients.
Pediatric Therapeutic Innovation
This clinician focuses on developing and evaluating new therapeutic approaches for pediatric patients with chronic gastrointestinal conditions. Their work involves assessing both established and emerging treatment modalities.
- Long-term Safety Assessment
- Pharmacokinetic Studies
- Clinical Remission Strategies
Their research extends to evaluating treatment efficacy in various age groups from early childhood through adolescence.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.